Abstract
The efficacy of a newly developed polyvalent bacterial lysat vaccine "Infectvac" was tested in experimental studies in animals. It was shown that a local application (oral, aerogenic) prevent the animals from a lethal bacterial (S. pneumoniae) or viral (A/PR/8/34) infection. In first clinical trials a good compatibility of the drug was demonstrated.
Publication types
-
Comparative Study
-
English Abstract
MeSH terms
-
Administration, Intranasal
-
Administration, Oral
-
Adult
-
Animals
-
Bacteria / immunology
-
Bacterial Infections / immunology
-
Bacterial Infections / prevention & control*
-
Bacterial Vaccines / administration & dosage*
-
Bacterial Vaccines / immunology
-
Female
-
Humans
-
Male
-
Mice
-
Mice, Inbred Strains
-
Respiratory Tract Infections / immunology
-
Respiratory Tract Infections / prevention & control*
-
Vaccines, Inactivated / administration & dosage
-
Vaccines, Inactivated / immunology
Substances
-
Bacterial Vaccines
-
Vaccines, Inactivated